Surmodics | SRDX - الدائنين التجاريين





الدائنين التجاريين تغيير تاريخ
Abbott USD 4.24B 117M 2025-12
Align Technology USD 123.72M 2.27M 2026-03
Anika Therapeutics USD 6.34M 298K 2026-03
Arrowhead Research USD 30.75M 2.19M 2026-03
Artivion USD 18.34M 2.3M 2026-03
Baxter International USD 1.09B 87M 2026-03
Boston Scientific USD 1.14B 3M 2026-03
EDAP TMS EUR 16.84M 1.7M 2025-09
Edwards Lifesciences USD 181.1M 46.4M 2026-03
Haemonetics USD 51.06M 2.36M 2026-03
Heron Therapeutics USD 8.97M 24K 2026-03
J&J USD 10.46B 1.53B 2026-03
Merit Medical Systems USD 67.85M 7.3M 2026-03
Mesa Laboratories USD 5.25M 163K 2025-12
Nektar Therapeutics USD 10.77M 4.79M 2025-12
Option Care Health USD 545.02M 94.81M 2026-03
Stryker USD 1.8B 301M 2025-12
Surmodics USD 5.93M 3.14M 2025-06
Trinity Biotech USD 30.36M 3.87M 2025-09